Bioavailability enhancement of baclofen by gastroretentive floating formulation: statistical optimization, in vitro and in vivo pharmacokinetic studies

References

• Ponchel G, Irache J. (1998). Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev, 34:191–219.
   PubMed Web of Science ®Google Scholar
• Singh BN, Kim KH. (2000). Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. J Control Release, 63:235–259.
   PubMed Web of Science ®Google Scholar
• Longer MA, Ch’ng HS, Robinson JR. (1985). Bioadhesive polymers as platforms for oral controlled drug delivery III: Oral delivery of chlorothiazide using a bioadhesive polymer. J Pharm Sci, 74:406–411.
   PubMed Web of Science ®Google Scholar
• Kumar RAA, Rao CSG, Reddy PV. (2009). Formulation and evaluation of swellable and floating gastroretentiv ciprofloxacin hydrochloride Tablets. AAPS Pharm Sci Tech, 10:220–226.
   PubMed Web of Science ®Google Scholar
• Nagarwal RC, Ridhurkar DN, Pandit JK. (2010). In vitro release kinetics and bioavailability of gastroretentive cinnarizine hydrochloride tablet. AAPS PharmSciTech, 11:294–303.
   PubMed Web of Science ®Google Scholar
• Baumgartner S, Kristl J, Vrecer F, Vodopivec P, Zorko B. (2000). Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm, 195:125–135.
   PubMed Web of Science ®Google Scholar
• Menon A, Ritschel WA, Sakr A. (1994). Development and evaluation of a monolithic floating dosage form for furosemide. J Pharm Sci, 83:239–245.
   PubMed Web of Science ®Google Scholar
• Timmermans J, Moës AJ. (1994). Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: New data for reconsidering the controversy. J Pharm Sci, 83:18–24.
   PubMed Web of Science ®Google Scholar
• Hilton AK, Deasy PB. (1992). In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxicillin trihydrate. Int J Pharm, 86:79–88.
   Web of Science ®Google Scholar
• Desai S, Bolton S. (1993). A floating controlled-release drug delivery system: In vitro-in vivo evaluation. Pharm Res, 10:1321–1325.
   PubMed Web of Science ®Google Scholar
• Narendra C, Srinath MS, Babu G. (2006). Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention. AAPS PharmSciTech, 7:E34.
   PubMed Web of Science ®Google Scholar
• Cedillo-Ramírez E, Villafuerte-Robles L, Hernández-León A. (2006). Effect of added Pharmatose DCL11 on the sustained-release of metronidazole from Methocel K4M and Carbopol 971P NF floating matrices. Drug Dev Ind Pharm, 32:955–965.
   PubMed Web of Science ®Google Scholar
• Sheth PR, Tossounian J. (1984). The hydrodynamically balanced system (HBSTM): A novel drug delivery system for oral use. Drug Dev Ind Pharm, 10:313–339.
   Web of Science ®Google Scholar
• Xiaoqiang X, Minjie S, Feng Z, Yiqiao H. (2006). Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: In vitro and in vivo evaluation in healthy volunteers. Int J Pharm, 310:139–145.
   PubMed Web of Science ®Google Scholar
• Shuang H, Feng L, Dan Z, Junrong D, Yuan H. (2011). Formulation and evaluation of novel coated floating tablet of bergenin and cetirizine dihydrochloride for gastric delivery. Drug Dev Ind Pharm, 1–9. DOI: 10.3109/03639045.2011.645836.
   Google Scholar
• Varshosaz J, Tavakoli N, Roozbahani F. (2006). Formulation and in vitro characterization of ciprofloxacin floating and bioadhesive extended-release tablets. Drug Deliv, 13:277–285.
   PubMed Web of Science ®Google Scholar
• Efentakis M, Peponaki C. (2008). Formulation study and evaluation of matrix and three-layer tablet sustained drug delivery systems based on Carbopols with isosorbite mononitrate. AAPS PharmSciTech, 9:917–923.
   PubMed Web of Science ®Google Scholar
• Al-Zoubi NM, AlKhatib HS, Obeidat WM. (2011). Evaluation of hydrophilic matrix tablets based on Carbopol(®) 971P and low-viscosity sodium alginate for pH-independent controlled drug release. Drug Dev Ind Pharm, 37:798–808.
   PubMed Web of Science ®Google Scholar
• Prajapati ST, Patel LD, Patel CN. (2009). Floating matrix tablets of domperidone: Formulation and optimization using simplex lattice design. Thai J Pharm Sci, 33:113–122.
   Google Scholar
• Rades T, Mueller-Goymann CC. (1998). Interactions between fenoprofen sodium and poly (ethylene oxide). Eur J Pharm Biopharm, 46:51–59.
   PubMed Web of Science ®Google Scholar
• Wise J, Conklin JL. (2004). Gastroesophageal reflux disease and baclofen: Is there a light at the end of the tunnel? Curr Gastroenterol Rep, 6:213–219.
   PubMedGoogle Scholar
• Martindale. (2005). The complete drug reference. 33rd ed. Chicago, IL: Pharmaceutical Press, 1758–1759.
   Google Scholar
• United States Pharmacopoeia and National Formulary (USP 30 NF 25). (2007). United States Pharmacopoeial Convention. Rockville, MD: 1482–1483.
   Google Scholar
• Ahuja, S. (1985). Baclofen. In: Florey K, ed. Analytical Profiles of Drug Substances and Excipients. Vol. 14. London, UK: Academic Press, 527–548.
   Google Scholar
• Merino M, Peris-Ribera JE, Torres-Molina F, Sánchez-Picó A, García-Carbonell MC, Casabó VG et al. (1989). Evidence of a specialized transport mechanism for the intestinal absorption of baclofen. Biopharm Drug Dispos, 10:279–297.
   PubMed Web of Science ®Google Scholar
• Bolton S, Bon C. (1997). Pharmaceutical statistics: Practical and clinical applications. 3rd ed. New York: Marcel Dekker In, 217–241.
   Google Scholar
• Roy P, Shahiwala A. (2009). Statistical optimization of ranitidine HCl floating pulsatile delivery system for chronotherapy of nocturnal acid breakthrough. Eur J Pharm Sci, 37:363–369.
   PubMed Web of Science ®Google Scholar
• Hintze J. (2004). NCSS and PASS. Number cruncher statistical systems. Kaysville, Utah.
   Google Scholar
• Box GEP, Wilson KB. (1951). On the experimental attainment of optimum conditions. J R Stat Soc B, 13:1–45.
   Google Scholar
• Jiménez-Castellano RM, Zia H, Rhodes T. (1994). Design and testing in vitro of a bioadhesive and a floating drug delivery for oral application. Int J Pharm, 105:65–70.
   Google Scholar
• Srivastava AK, Wadhwa S, Ridhurkar D, Mishra B. (2005). Oral sustained delivery of atenolol from floating matrix tablets-formulation and in vitro evaluation. Drug Dev Ind Pharm, 31:367–374.
   PubMed Web of Science ®Google Scholar
• Gohel MC, Mehta, PK, Dave PR, Baria NH. (2005). More relevant dissolution method for evaluation of FDDS. Dissolution Technol, 11:22–25.
   Google Scholar
• Lamoudi L, Chaumeil JC, Daoud K. (2012). Development of gastro intestinal sustained release tablet formulation containing acryl-EZE and pH-dependent swelling HPMC K 15 M. Drug Dev Ind Pharm, 38:515–520.
   PubMed Web of Science ®Google Scholar
• Sahoo AK, Singh SK, Varma A. (2011). Formulation development of buoyant controlled release tablets containing chitosan: Optimization of in vitro dissolution and release kinetics. Int J Pharm Pharm Sci, 3:81–85.
   Google Scholar
• Ozdemir N, Ordu S, Ozkan Y. (2000). Studies of floating dosage forms of furosemide: In vitro and in vivo evaluations of bilayer tablet formulations. Drug Dev Ind Pharm, 26:857–866.
   PubMed Web of Science ®Google Scholar
• Millerioux L, Brault M, Gualano V, Mignot A. (1996). High-performance liquid chromatographic determination of baclofen in human plasma. J Chromatogr A, 729:309–314.
   PubMed Web of Science ®Google Scholar
• Liandong H, Xun Yang L, Wei L, Jianxue Y, Yanhong J, Chuang S, Hongxin X. (2011). Floating matrix dosage form for dextromethorphan hydrobromide based on gas forming technique: In vitro and in vivo evaluation in healthy volunteers. Eur J Pharm Sci, 42:99–105.
   PubMed Web of Science ®Google Scholar
• Dev RK, Bali V, Pathak K. (2011). Novel microbially triggered colon specific delivery system of 5-Fluorouracil: Statistical optimization, in vitro, in vivo, cytotoxic and stability assessment. Int J Pharm, 411:142–151.
   PubMed Web of Science ®Google Scholar
• Indian Pharmacopoeia. (2007). Ministry of health and family welfare, Indian pharmacopoeia commission, Ghaziabad, India, 2150–2153.
   Google Scholar
• Efentakis M, Naseef H, Vlachou M. (2010). Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs. Drug Dev Ind Pharm, 36:903–916.
   PubMed Web of Science ®Google Scholar
• Armstrong, AN, James, KC. (1996). Pharmaceutical experimental design and interpretation. 2nd ed. Bristol, PA: Taylor and Francis Publishers, 131–192.
   Google Scholar
• Adinarayana K, Ellaiah P. (2002). Response surface optimization of the critical medium components for the production of alkaline protease by a newly isolated Bacillus sp. J Pharm Pharm Sci, 5:272–278.
   PubMed Web of Science ®Google Scholar
• Siepmann J, Peppas NA. (2001). Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 48:139–157.
   PubMed Web of Science ®Google Scholar
• Mostafavi A, Emami J, Varshosaz J, Davies NM, Rezazadeh M. (2011). Development of a prolonged-release gastroretentive tablet formulation of ciprofloxacin hydrochloride: Pharmacokinetic characterization in healthy human volunteers. Int J Pharm, 409:128–136.
   PubMed Web of Science ®Google Scholar
• Dhawan S, Dhawan K, Varma M, Sinha VR. (2005). Application of poly (ethylene oxide) in drug delivery systems. Pharm Technol, 29:72–80.
   Google Scholar